Search

Your search keyword '"Paterson, Aimee"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Paterson, Aimee" Remove constraint Author: "Paterson, Aimee"
46 results on '"Paterson, Aimee"'

Search Results

2. Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution

3. Decline of Antibodies to Major Viral and Bacterial Respiratory Pathogens During the COVID-19 Pandemic.

4. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection

5. Epidemiology of healthcare-associated Pseudomonas aeruginosa in intensive care units: Are sink drains to blame?

6. Hands-on refinements: establishing improved husbandry processes for aged C57BL/6 mice.

10. Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naïve New Zealand cohort

11. Coronavirus disease 2019 (COVID-19) outbreak on an in-patient medical unit associated with unrecognized exposures in common areas—Epidemiological and whole-genome sequencing investigation

12. The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccine

13. Deciphering TP53 mutant Cancer Evolution with Single-Cell Multi-Omics

14. 3170 – SINGLE-CELL MULTI-OMICS RESOLVES THE EVOLUTION OF TP53-MUTANT LEUKEMIA

15. A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination

16. Surface and air contamination with SARS-CoV-2 from hospitalized COVID-19 patients in Toronto, Canada, March-May 2020

17. Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March–May 2020

18. Single-Cell Multi-Omics Reveals the Genetic, Cellular and Molecular Landscape of TP53 Mutated Leukemic Transformation in MPN

19. A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination

20. Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers

21. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection

22. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in patients with COVID-19

23. Cooperation between SF3B1 and JAK2V617F Mutations Accelerates Fibrotic Progression in Myeloproliferative Neoplasms By Enhancing STAT1 Signaling

24. Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2

25. Surface and air contamination with SARS-CoV-2 from hospitalized COVID-19 patients in Toronto, Canada

26. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients

27. 837. Contamination of Hospital Drains by Carbapenemase-Producing Enterobacterales (CPE) in Ontario, Canada

28. Household Transmission of Carbapenemase-producing Enterobacterales in Ontario, Canada

29. Mucosal versus systemic antibody responses to SARS-CoV-2 antigens in COVID-19 patients

30. 1228. Risk Factors for Contamination with Carbapenemase-Producing Enterobacteriales (CPE) in Exposed Hospital Drains in Ontario, Canada

31. 1224. Factors Associated with Aerosolization of Gammaproteobacteria from Intensive Care Unit (ICU) Sinks in a Randomized Trial of Copper Alloy vs. Standard Chrome Sink Drains

32. 501. Risk of Infection in Persons Colonized with Carbapenemase-Producing Enterobacteriales (CPE) in Ontario, Canada

33. 2165. Risk Factors for CPE Colonization in Household Contacts of CPE Colonized/Infected Patients

34. 1186. Prevalence of Carbapenemase-Producing Enterobacteriaceae (CPE) in Hospital Drains in Southern Ontario

37. Retrospective Evaluation of Accelerate Pheno™ System (AXDX, Version 1.1) for Identification/Antimicrobial Susceptibility Testing (ID/AST) of Gram-Negative Bacilli (GNB) including Carbapenemase-Producing Organisms (CPO) from Seeded Blood Culture Bottles (SBCB) Tested using AXDX PhenoTestTM BC Kits

38. Prospective Evaluation of Accelerate Pheno™ System (AXDX) Version 1.1 for Reducing Turn-Around-Time (TAT) in Identification/Antimicrobial Susceptibility Testing (ID/AST) of Gram-Negative Bacilli (GNB) from Positive Blood Cultures (+BC) using AXDX PhenoTest™ BC Kits

39. Prevalence of Carbapenemase-Producing Enterobacteriaceae (CPE) in Hospital Drains and Relationship to Patient Isolates in Toronto, Canada

40. Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2.

41. Sensitivity of midturbinate versus nasopharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

42. Cooperation between SF3B1and JAK2V617FMutations Accelerates Fibrotic Progression in Myeloproliferative Neoplasms By Enhancing STAT1 Signaling

43. Single-Cell Multi-Omics Reveals the Genetic, Cellular and Molecular Landscape of TP53Mutated Leukemic Transformation in MPN

44. Rapid inference of antibiotic susceptibility phenotype of uropathogens using metagenomic sequencing with neighbor typing.

45. Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March-May 2020.

46. Household Transmission of Carbapenemase-producing Enterobacterales in Ontario, Canada.

Catalog

Books, media, physical & digital resources